Clinical trial
The Effect of Antihypertensive Medication Timing on Morbidity and Mortality: The "BedMed" RCT
NCT02990663 is registered in ClinicalTrials.gov with University of Alberta as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effect of Antihypertensive Medication Timing on Morbidity and Mortality: The "BedMed" RCT
- Lead sponsor
- University of Alberta
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- March 31, 2017
- Completion date
- December 22, 2023
- Enrollment
- 3,357 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.